Kelly Huang, PhD
Chief Operating Officer of L-Nutra, Inc.
Dr. Kelly Huang is Chief Operating Officer of L-Nutra, Inc. Previously, he held the positions of President, CEO, and Board Director for Obalon Therapeutics, a publicly traded medical weight-loss device company.
Dr. Huang also held the title of General Manager of Nestle Skin Health's Galderma LP Aesthetics business, providing commercial leadership for iconic brands like Restylane, Dysport, and Sculptra. At Endo Pharmaceuticals, he served as President of the urology device & services business unit, HealthTronics, and was a member of Endo’s Executive Committee, responsible for strategic leadership across the Branded & Generic Pharmaceuticals, Medical Devices, and Medical Services sectors. Before Endo, Kelly was with Johnson & Johnson for 16 years, including Vice President with Johnson & Johnson's Development Corporation and on the management teams of Neutrogena and RoC Skincare.
He currently serves on the board of Sanova Dermatology, the Princeton Innovation Accelerator (USA Hub of Commonwealth Center for Digital Health), and on the editorial board of American Drug and Health Benefits. Kelly is also a Leadership Fellow with the National Association of Corporate Directors and serves as a Managing Director at Spindletop Capital, a healthcare-focused private equity firm.
Dr. Huang obtained his PhD and MS degrees in Chemical Engineering from Stanford University. He also holds a BS in Chemical Engineering, with a minor in Chemistry from the University of Massachusetts at Amherst.